From: Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5
Primary tissue | Unique mutated samples | % mutated | Total unique samples | Mutation data | references |
---|---|---|---|---|---|
bilary tract | 0 | 0% | 2 | Â | Â |
breast | 0 | 0% | 201 | Â | Â |
CNS | 0 | 0% | 477 | Â | Â |
haematopoietic and lymphoid tissue | 0 | 0% | 27 | Â | Â |
kidney | 0 | 0% | 28 | Â | Â |
large intestine | 0 | 0% | 42 | Â | Â |
lung | 3 | 1% | 359 | c.190 C > T : R64C | [48] |
c.700 G > T: G234C | [48] | ||||
c.868 C > G: L290V | [48] | ||||
ovary | 1 | 1% | 85 | c.1466A > C: K489T | [50] |
pancreas | 0 | 0% | 31 | Â | Â |
pleura | 0 | 0% | 1 | Â | Â |
prostate | 0 | 0% | 58 | Â | Â |
salivary gland | 0 | 0% | 9 | Â | Â |
skin | 2 | 25% | 8 | c.868 C > G: L290V | [51] |
c.1522 G > A: E508K | [51] | ||||
stomach | 0 | 0% | 34 | Â | Â |
testis | 0 | 0% | 13 | Â | Â |
upper aerodigestive tract | 0 | 0% | 19 | Â | Â |
urinary tract | 0 | 0% | 2 | Â | Â |